Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in Rituximab-resistant Indolent B-Cell Non-Hodgkin's Lymphomas
NCT04569838Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- May 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in B-cell non-Hodgkin lymphoma, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started May 2012; status: completed.
02
Drugs
bendamustine
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT04569838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569838.